Microvascular Dysfunction in Hyperhomocysteinemia

Information

  • Research Project
  • 8232488
  • ApplicationId
    8232488
  • Core Project Number
    R15HL106548
  • Full Project Number
    1R15HL106548-01A1
  • Serial Number
    106548
  • FOA Number
    PA-10-070
  • Sub Project Id
  • Project Start Date
    3/15/2012 - 12 years ago
  • Project End Date
    2/29/2016 - 8 years ago
  • Program Officer Name
    GAO, YUNLING
  • Budget Start Date
    3/15/2012 - 12 years ago
  • Budget End Date
    2/29/2016 - 8 years ago
  • Fiscal Year
    2012
  • Support Year
    01
  • Suffix
    A1
  • Award Notice Date
    3/6/2012 - 12 years ago
Organizations

Microvascular Dysfunction in Hyperhomocysteinemia

DESCRIPTION (provided by applicant): Longitudinal transmission of vasodilatory signals along microvascular arterioles (conducted vasodilation; CVD) underlies the coordination of blood flow within microvascular networks and is an important mechanism for integrating tissue perfusion and peripheral resistance. Little is known of how disease alters CVD within a microvascular network. Elevated blood concentration of homocysteine (hyperhomocysteinemia; HHcy) is a risk factor for several cardiovascular diseases. Though HHcy impairs microvascular reactivity to pharmacologic vasodilators, nothing is known of the functional deficits of microvascular blood flow control in HHcy. Based on pilot data and published literature, our working hypothesis is that HHcy impairs coordination of blood flow control in skeletal muscle by reducing cell-cell communication through gap junction and that this impairment can be reversed by exercise training. In Aim 1, we will explore a set of potential mechanisms for homocysteine-mediated dysfunction in conducted vasodilation and the connexins proteins that form gap junction communication pathways. Pilot data show that homocysteine disrupts CVD and increases serine phosphorylation of both connexin40 and connexin43, which are responsible for endothelial cell-cell (EC-EC) and endothelial-smooth muscle cell (EC-SMC; myoendothelial) communication. We develop the novel hypothesis that homocysteine activates metabotropic glutamate receptors on endothelial cells, mediating a G-protein cascade through phosphokinase C (PKC) and serine phosphorylation of these gap junction components. We will test this hypothesis using 1) a new co-culture system with primary EC and SMC from skeletal muscle microvessels, allowing for the first time the distinct isolation of myoendothelial junctions, and 2) isolated skeletal muscle arterioles in vitro. In Aim 2, we will evaluate the effects of exercise training on ascending vasodilation in HHcy. CVD that ascends from contracting skeletal muscle into respective feed arteries (ascending vasodilation; AVD) is an essential component of exercise hyperemia. Pilot data from mice with mild HHcy (deficiency in the homocysteine-metabolizing enzyme, CBS v wild type littermates) indicate an impaired capacity for AVD in response to muscle contraction. Electron microscopy shows significant changes in the morphology of myoendothelial junctions in skeletal muscle arterioles. Unfortunately, there are currently no efficacious clinical interventions for mild to moderate hyperhomocysteinemia. Using intravital microscopy of CBS and mice in vivo, we will test the hypothesis that exercise training can reverse homocysteine- mediated deficits in AVD and reverse structural deficits at the myoendothelial junction. Collectively, these experiments will provide new understanding of the microvascular dysfunction caused by HHcy, a risk factor for cardiovascular disease, venous thromboembolism, stroke, and Alzheimer disease. PUBLIC HEALTH RELEVANCE: The lining of the microvasculature, the endothelium, communicates nutrient needs of cells to upstream vessels via gap junctional coupling, thereby matching local metabolic needs with upstream vasodilation. Hyperhomocysteinemia, a risk factor for cardiovascular and neurocognitive disease, disrupts endothelial gap junctional communication. This project will 1) identify the mechanisms by which homocysteine disrupts this communication pathway and 2) elucidate the effects of exercise training on reversing the effects of hyperhomocysteinemia and restoring this vital communication pathway.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R15
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
    271360
  • Indirect Cost Amount
    74982
  • Total Cost
    346342
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    837
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NHLBI:346342\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    HM
  • Study Section Name
    Hypertension and Microcirculation Study Section
  • Organization Name
    IDAHO STATE UNIVERSITY
  • Organization Department
    BIOLOGY
  • Organization DUNS
    078341468
  • Organization City
    POCATELLO
  • Organization State
    ID
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    832098046
  • Organization District
    UNITED STATES